Artificial Intelligence

The firm, recognized as EMEA's top MSSP, is pioneering an 'Agentic SOC' model that moves cyber defense beyond human limitations to an AI-driven future.

A novel drug candidate from Addex Therapeutics shows robust cough suppression in key preclinical studies, offering hope for a treatment without current side effects.

Microsoft and North America's Building Trades Unions are launching free AI courses for millions, aiming to future-proof the skilled trades workforce.

Arçelik secures up to $261M by selling its Hitachi JV stake, part of a larger deal that sees retailer Nojima acquire Hitachi's entire appliance arm.

The software giant joins the CHERI Alliance and lands a UK contract to bring hardware-enforced memory protection to mission-critical RISC-V systems.

At Money20/20, EurewaX launched its Payment Platform as a Service, aiming to empower Asian firms with rapid, AI-driven global payment capabilities.

With record global attendance and a focus on AI, drones, and sustainability, CCE 2026 in Shanghai showcased a cleaning industry in radical transformation.

Fintech giant RedotPay integrates SUI and Native USDC, unlocking seamless, low-cost global payments for its 7 million users on the high-speed Sui network.

With a fresh $60 million IPO, JATT II is targeting the next wave of healthcare innovators using AI and machine learning to revolutionize drug discovery.

The acquisition of Canadian favorite Libro gives OpenTable a Quebec stronghold, but will local restaurants embrace the global giant's embrace?

With a $719M war chest from its blockbuster IPO, Kailera Therapeutics is poised to challenge the dominance of Lilly and Novo in the lucrative obesity market.

A novel 'payload-bearing' drug shows potent preclinical activity against a rare pediatric cancer, paving an accelerated path to human trials.

As IPO markets revive, advisory firms say patient private equity capital and rigorous prep are the keys for companies hoping to go public successfully.

Australian GRC leader Protecht buys US-based VISO TRUST, integrating advanced AI to automate security and dominate the rapidly expanding risk management market.

With a history of strong growth but a volatile stock, Paymentus's upcoming Q1 2026 earnings report on May 4 is a critical moment for investors.

Beyond generic image generators, Sunvega's specialized AI creates production-ready blueprints, transforming home design from the showroom to the factory floor.

Following a breakthrough in chondrosarcoma, Inhibrx Biosciences is set to reveal pivotal data for its drug ozekibart in the vast colorectal cancer market.

The AI-native startup is transforming books into living aiBook™ experiences, aiming to reshape the $150 billion publishing industry from within.

Marigold appoints a new Chief AI Officer and CPTO, signaling a major strategic push to embed advanced intelligence across its marketing platforms.

The new SGRD fund offers investors a targeted play on the multi-billion dollar overhaul of global electricity grids, a critical, overlooked sector.